Category:Chemotherapy
From WikiMD's Food, Medicine & Wellnesspedia
(Redirected from Category:Antineoplastic agents)
Subcategories
This category has only the following subcategory.
E
Pages in category "Chemotherapy"
The following 200 pages are in this category, out of 346 total.
(previous page) (next page)- 10-deacetyltaxol
- 2,6-diaminopurine
- 2-fluoroadenine
- 2-hydroxyestrone
- 2-methoxyestrone
- A-65
- Alpelisib
- Alvespimycin
- Aminopterin sodium
- Amrubicin hydrochloride
- Andrographolide
- Antineoplastic activity.
- Template:Antineoplastic-agents-stub
- Antineoplastics
- Aranose
- Asparaginase erwinia chrysanthemi
- Avadomide
- Avapritinib
- Axalimogene filolisbac
- Azaserine
- Bactobolin
- Bardoxolone methyl
- Bcg vaccine
- Belantamab mafodotin
- Belapectin
- Belvarafenib
- Bemcentinib
- Bempegaldesleukin
- Berzosertib
- Birabresib
- Brivanib alaninate
- Caffeic acid phenethyl ester
- Calcium saccharate
- Cancer drugs
- Capivasertib
- Capmatinib
- Carubicin
- Cedazuridine
- Cerdulatinib
- Chromomycin a3
- Cisplatin
- Clivatuzumab
- Coltuximab ravtansine
- Conbercept
- Devimistat
- DHAP regimen
- Dibrospidium chloride
- Dovitinib
- Dromostanolone propionate
- Dynemicin a
- Eftilagimod alpha
- Enclomiphene
- Entolimod
- Envafolimab
- Ethylnitrosourea
- Favezelimab
- Fermented wheat germ extract
- Fosbretabulin
- Fosbretabulin disodium
- Fruquintinib
- Gadopiclenol
- Gag:267-274 peptide vaccine
- Galunisertib
- Gandotinib
- Gedatolisib
- Gonadotropin-releasing hormone analog
- Hexylresorcinol
- Iberdomide
- Imetelstat
- Infigratinib
- Interferon alfa-n3
- Iodine i 131 tositumomab
- Irosustat
- Lifileucel
- Linrodostat
- List of chemotherapeutic agents
- Lorlatinib
- Mart-1 antigen
- Mavelertinib
- Mavorixafor
- Melphalan flufenamide
- Milataxel
- Mitomycin
- Mitomycin Pyelocalyceal
- Motixafortide
- Motolimod
- Nab-paclitaxel
- Nocodazole
- Odronextamab
- Ofranergene obadenovec
- Paclitaxel trevatide
- Pamiparib
- Patritumab deruxtecan
- Pegilodecakin
- Pexastimogene devacirepvec
- Pexidartinib
- Pictilisib
- Pimitespib
- Pimurutamab
- Pingyangmycin
- Polysialic acid
- Pralsetinib
- Repotrectinib
- Retinyl acetate
- Ripretinib
- Rosabulin
- Savolitinib
- Scopoletin
- Selpercatinib
- Silibinin
- Sipuleucel-t
- Sivifene
- Sonolisib
- Sotorasib
- Taselisib
- Tasquinimod
- Tazemetostat
- Temozolomide
- Tepotinib
- Tetrathiomolybdate
- Thiodiglycol
- Tirbanibulin
- Topical chemotherapy
- Transferrin-crm107
- Trilaciclib
- Troriluzole
- Upamostat
- Ursolic acid
- Valemetostat
- VeIP
- Vinflunine ditartrate
- Vorasidenib
- Vosilasarm
- Voxtalisib
- Zebularine
- Zolbetuximab
A
- AC
- Acivicin
- ADE (chemotherapy)
- Aderbasib
- Adjuvant chemotherapy
- Aldophosphamide
- Alkylating antineoplastic agent
- ANG1005
- Anti-Cancer Drugs
- Antibiotics and Chemotherapy
- Antibiotics And Chemotherapy
- Antimetabolite
- Antimicrotubule agent
- Antimitotic agent
- Antineoplastic agents
- Apaziquone
- Arsphenamine
- Azasetron
B
C
- Cancer chemotherapy
- Carboxycyclophosphamide
- Carboxyphosphamide
- Casopitant
- Celilo
- Chemoradiotherapy
- Chemosensitivity assay
- Chemotactic drug-targeting
- Chemotherapeutic adjuvants
- Chemotherapeutic agent
- Chemotherapy
- Chemotherapy drug
- Chemotherapy regimen
- Chemotherapy regimens
- Chemotherapy regimens used in breast cancer
- Chemotherapy regimens used in colorectal cancer
- Chemotherapy-induced acral erythema
- Chemotherapy-induced hyperpigmentation
- Chemotherapy-induced Nausea And Vomiting
- Clocental
- Combretastatin A-4 Phosphate
- Continuous hyperthermic peritoneal perfusion
- CUSP9
- Cytotoxic agent
